Antioxidant activity of tellimagrandin I, pedunculagin, and vescalagin/castalagin
Compound | ABTS | FRAP | DPPH | Lipoperoxidation | Reference |
---|---|---|---|---|---|
Tellimagrandin I | - | - | - | 51.34% ± 0.72% | [76] |
Tellimagrandin I | 255.9 mmol/100 g ± 8.48 mmol/100 g | 210.62 mmol/100 g ± 5.45 mmol/100 g | 191.00 mmol ± 0.04 mmol of Tx/100 g | - | [74] |
Tellimagradin I | - | - | 1.45 µg/mL ± 0.02 µg/mL | 71.47% ± 5.64% | [77] |
Tellimagrandin I | 54.5 μmol/L ± 0.6 μmol/L | - | 73.5 μmol/L ± 2.5 μmol/L | - | [79] |
Tellimagrandin I | 73.6 μmol/L ± 3.2 μmol/L | - | 65.8 μmol/L ± 1.2 μmol/L | - | [79] |
Pedunculagin | 83.69% ± 4.28% inhibition 0.111 mg/mL | - | 0.139 mg/mL | - | [83] |
Tellimagrandin I | 0.03 μmol/L ± 0.02 µmol/L Tx equivalent/µg | - | 94.65% ± 0.29% | - | [65] |
Pedunculagin | 10.8 μg/mL ± 0.7 μg/mL | - | - | - | [80] |
Vescalagin | - | - | 5 mg/mL | - | [44] |
Castalagin | - | - | 4 mg/mL | - | [44] |
Vescalagin/Castalagin | - | - | 4,455 mg ± 15 mg AAE/100 g | 86% ± 1% | [70] |
Vescalagin/Castalagin | - | - | 33.643 mmol ± 3.129 mmol of Tx/100 g | - | [82] |
Pedunculagin | - | - | 1.55 µmol ± 0.12 µmol of Tx equivalent/µmol | - | [37] |
Tellimagrandin I | - | - | 1.33 µmol ± 0.03 µmol of Tx equivalent/µmol | - | [37] |
AAE: ascorbic acid equivalent; -: not involving